(S)-4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylic Acid

4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide

active pharmaceutical ingredient

فينيرانون

mineralocorticoid receptor antagonist

2-Cyanoethyl (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-1,6-naphthyridine-3-carboxylate

pharmaceutical intermediate for finerenone

5-Desethoxy,-5-Methoxy-Finerenone

Mineralocorticoid receptor antagonist intermediate

2-Cyanoethyl 2-(4-cyano-2-methoxybenzylidene)-3-oxobutanoate

Pharmaceutical intermediate for finerenone

Finerenone metabolite M2

Pharmaceutical intermediate for finerenone

Methyl 16-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenyl-methoxy]methyl]-4-[2-cyanoethoxy-(diisopropylamino)phosphanyl]oxy-2-(2,4-dioxopyrimidin-1-yl)tetrahydrofuran-3-yl]oxyhexadecanoate

phosphoramidite building block for oligonucleotide synthesis

N-(4-(2,2-Dicyano-1-hydroxyvinyl)benzyl)-5-fluoro-2-methoxybenzamide

Pharmaceutical intermediate